Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹16.1 LQualified 43 A OKHLA INDUSTRIAL ESTATE PHASE III NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | L1 | Qualified |
Tender Value
₹16.1 L
EMD Value
Exempted
Closing Date
20 Jan 2025, 1:00 pmClosed
Line Probe Assay Kit for First Line Drugs under NTEP (Q1) ( PAC Only )
7353424
GEM/2025/B/5799151
Two Packet Bid
Line Probe Assay Kit for First Line Drugs under NTEP (Q1) ( PAC Only )
GeM Contract
30 days
Kumar282002State TB Training Demonstration Centre UP, Moti Katra Road, Adjacent S N Medical College, AGRA UP
Total value wise evaluation
PRODUCT
Awarded to BIOMERIEUX INDIA PRIVATE LIMITED
₹16.1 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| HAIN LIFESCIENCE Line Probe Assay Kit for First Line Drugs | HAIN LIFESCIENCE / Genotype MTBDRplus V2 (96Tests) | HSN not specified by seller | 20 pieces | 80,634 | 1,612,680 |
6 documents required · 6 mandatory
1 yrs
₹3
10%
Exempted
31 Jan 2025
9 Jan 2025
20 Jan 2025
HAIN LIFESCIENCE Line Probe Assay Kit for First Line Drugs | Brand:HAIN LIFESCIENCE | Model:Genotype MTBDRplus V2 (96Tests) | HSN:HSN not specified by seller | Qty:20 pieces | UnitPrice:80,634 | Amount:1,612,680
contract_GEMC-511687727873661.pdf
GEM_CONTRACT • 0.07 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7353424.pdf
GEM_BID
1736407751.pdf
OTHER
line_probe_assay_for_first_line_drugs_2024-07-05-17-12-42_a1cae39c6006b56298b42101610a7930.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .